in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MD
4:00 AM MDT | July 1, 2008 | Alex Scott
Contract fine chemicals firm Lonza (Basel, Switzerland) says it has secured a deal with biotech firm Osiris Therapeutics (Columbia, MD) to manufacture what could be the world’s first stem cell drug. Lonza will build a new manufacturing facility at its Walkersville, MD site to manufacture the drug, the company says. Lonza has stated that the new manufacturing facility will cost millions of dollars to set up. Terms between the two companies were not disclosed. Under the terms of the agreement Lonza will manufacture Osiris’s Prochymal stem cell...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee